Computer-generated “synthetic contingency” plans at times of logistics and supply problems: scenarios for hydroxychloroquine and remdesivir
Author:
Affiliation:
1. Institute of Organic Chemistry
2. Polish Academy of Sciences
3. Warsaw 02-224
4. Poland
5. IBS Center for Soft and Living Matter
Abstract
A computer program for retrosynthetic planning helps develop multiple “synthetic contingency” plans for hydroxychloroquine and also routes leading to remdesivir, both promising but yet unproven medications against COVID-19.
Funder
Narodowe Centrum Nauki
Institute for Basic Science
Defense Advanced Research Projects Agency
Publisher
Royal Society of Chemistry (RSC)
Subject
General Chemistry
Link
http://pubs.rsc.org/en/content/articlepdf/2020/SC/D0SC01799J
Reference35 articles.
1. Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro
2. Hydroxychloroquine, a less toxic derivative of chloroquine, is effective in inhibiting SARS-CoV-2 infection in vitro
3. Chloroquine inhibits autophagic flux by decreasing autophagosome-lysosome fusion
4. Targeted crystallization of mixed-charge nanoparticles in lysosomes induces selective death of cancer cells
Cited by 12 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Process Development for the Manufacture of the Antimalarial Amodiaquine Dihydrochloride Dihydrate;Organic Process Research & Development;2023-12-18
2. Recent progress on drugs discovery study for treatment of COVID-19: repurposing existing drugs and current natural bioactive molecules;Applied Biological Chemistry;2023-12-13
3. Synthesis of novel 2- and 8-substituted 4-amino-7-chloroquinolines and their N-alkylated coupling products;Canadian Journal of Chemistry;2023-08-01
4. Optimized synthesis of anti-COVID-19 drugs aided by retrosynthesis software;RSC Medicinal Chemistry;2023
5. Application of artificial intelligence and big data technology in synthesis planning;SCIENTIA SINICA Chimica;2022-12-12
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3